2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Arsenic modifies the effect of folic acid in spina bifida prevention, a large hospital-based case-control study in Bangladesh

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Spina bifida, a developmental malformation of the spinal cord, is associated with high rates of mortality and disability. Although folic acid-based preventive strategies have been successful in reducing rates of spina bifida, some areas continue to be at higher risk because of chemical exposures. Bangladesh has high arsenic exposures through contaminated drinking water and high rates of spina bifida. This study examines the relationships between mother’s arsenic exposure, folic acid, and spina bifida risk in Bangladesh.

          Methods

          We conducted a hospital-based case-control study at the National Institute of Neurosciences & Hospital (NINS&H) in Dhaka, Bangladesh, between December 2016 and December 2022. Cases were infants under age one year with spina bifida and further classified by a neurosurgeon and imaging. Controls were drawn from children seen at NINS&H and nearby Dhaka Shishu Hospital. Mothers reported folic acid use during pregnancy, and we assessed folate status with serum assays. Arsenic exposure was estimated in drinking water using graphite furnace atomic absorption spectrophotometry (GF-AAS) and in toenails using inductively coupled plasma mass spectrometry (ICP-MS). We used logistic regression to examine the associations between arsenic and spina bifida. We used stratified models to examine the associations between folic acid and spina bifida at different levels of arsenic exposure.

          Results

          We evaluated data from 294 cases of spina bifida and 163 controls. We did not find a main effect of mother’s arsenic exposure on spina bifida risk. However, in stratified analyses, folic acid use was associated with lower odds of spina bifida (adjusted odds ratio [OR]: 0.50, 95% confidence interval [CI]: 0.25-1.00, p = 0.05) among women with toenail arsenic concentrations below the median value of 0.46 µg/g, and no association was seen among mothers with toenail arsenic concentrations higher than 0.46 µg/g (adjusted OR: 1.09, 95% CI: 0.52–2.29, p = 0.82).

          Conclusions

          Mother’s arsenic exposure modified the protective association of folic acid with spina bifida. Increased surveillance and additional preventive strategies, such as folic acid fortification and reduction of arsenic, are needed in areas of high arsenic exposure.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12940-024-01091-1.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Effects and safety of periconceptional oral folate supplementation for preventing birth defects

          Cochrane Database of Systematic Reviews
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis : Worldwide neural tube defects: estimates for 2015

            Neural tube defects (NTDs) are associated with substantial mortality, morbidity, disability, and psychological and economic costs. Many are preventable with folic acid, and access to appropriate services for those affected can improve survival and quality of life. We used a compartmental model to estimate global and regional birth prevalence of NTDs (live births, stillbirths, and elective terminations of pregnancy) and subsequent under-5 mortality. Data were identified through web-based reviews of birth defect registry databases and systematic literature reviews. Meta-analyses were undertaken where appropriate. For 2015, our model estimated 260,100 (uncertainty interval (UI): 213,800-322,000) NTD-affected birth outcomes worldwide (prevalence 18.6 (15.3-23.0)/10,000 live births). Approximately 50% of cases were elective terminations of pregnancy for fetal anomalies (UI: 59,300 (47,900-74,500)) or stillbirths (57,800 (UI: 35,000-88,600)). Of NTD-affected live births, 117,900 (∼75%) (UI: 105,500-186,600) resulted in under-5 deaths. Our systematic review showed a paucity of high-quality data in the regions of the world with the highest burden. Despite knowledge about prevention, NTDs remain highly prevalent worldwide. Lack of surveillance and incomplete ascertainment of affected pregnancies make NTDs invisible to policy makers. Improved surveillance of all adverse outcomes is needed to improve the robustness of total NTD prevalence estimation, evaluate effectiveness of prevention through folic acid fortification, and improve outcomes through care and rehabilitation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The continuing challenge of understanding, preventing, and treating neural tube defects.

              Human birth defects are a major public health burden: The Center for Disease Control estimates that 1 of every 33 United States newborns presents with a birth defect, and worldwide the estimate approaches 6% of all births. Among the most common and debilitating of human birth defects are those affecting the formation of the neural tube, the precursor to the central nervous system. Neural tube defects (NTDs) arise from a complex combination of genetic and environmental interactions. Although substantial advances have been made in the prevention and treatment of these malformations, NTDs remain a substantial public health problem, and we are only now beginning to understand their etiology. Here, we review the process of neural tube development and how defects in this process lead to NTDs, both in humans and in the animal models that serve to inform our understanding of these processes. The insights we are gaining will help generate new intervention strategies to tackle the clinical challenges and to alleviate the personal and societal burdens that accompany these defects.
                Bookmark

                Author and article information

                Contributors
                maitreyi.mazumdar@childrens.harvard.edu
                Journal
                Environ Health
                Environ Health
                Environmental Health
                BioMed Central (London )
                1476-069X
                3 June 2024
                3 June 2024
                2024
                : 23
                : 51
                Affiliations
                [1 ]GRID grid.38142.3c, ISNI 000000041936754X, Department of Environmental Health, , Harvard T.H. Chan School of Public Health, ; 655 Huntington Avenue, Boston, MA 02115 USA
                [2 ]Department of Paediatric Neurosurgery, National Institute of Neurosciences & Hospital, ( https://ror.org/02qs4wf90) Sher-e-Bangla Nagar, Agargoan, Dhaka 1207 Bangladesh
                [3 ]Department of Clinical Neurosurgery, National Institute of Neurosciences & Hospital, ( https://ror.org/02qs4wf90) Sher-e-Bangla Nagar, Agargoan, Dhaka 1207 Bangladesh
                [4 ]Dhaka Shishu Hospital, ( https://ror.org/039cbw303) Dhaka, Bangladesh
                [5 ]Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University (BSMMU), ( https://ror.org/042mrsz23) Dhaka, Bangladesh
                [6 ]Department of Epidemiology and Population Health, Stanford University, ( https://ror.org/00f54p054) Palo Alto, , 300 Pasteur Drive, CA 94305 USA
                [7 ]Pediatric Neurosurgery Research Committee, National Institute of Neurosciences & Hospital, ( https://ror.org/02qs4wf90) Sher-e-Bangla Nagar, Agargoan, Dhaka 1207 Bangladesh
                [8 ]Department of Neurology, Boston Children’s Hospital, ( https://ror.org/00dvg7y05) BCH3443, 300 Longwood Ave, Boston, MA 02115 USA
                [9 ]GRID grid.38142.3c, ISNI 000000041936754X, Department of Biostatistics, , Harvard T.H. Chan School of Public Health, ; 655 Huntington Avenue, Boston, MA 02115 USA
                [10 ]Department of Neurosurgery, Boston Children’s Hospital, ( https://ror.org/00dvg7y05) 300 Longwood Avenue, Boston, MA 02115 USA
                Article
                1091
                10.1186/s12940-024-01091-1
                11145859
                38831396
                b03d2132-2ee8-4053-8ea9-8c2192492e0c
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 25 February 2024
                : 19 May 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000025, National Institute of Mental Health;
                Award ID: T32 MH112510
                Funded by: FundRef http://dx.doi.org/10.13039/100000066, National Institute of Environmental Health Sciences;
                Award ID: R01 ES026317
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Public health
                arsenic,bangladesh,folic acid,spina bifida
                Public health
                arsenic, bangladesh, folic acid, spina bifida

                Comments

                Comment on this article